(Total Views: 95)
Posted On: 02/23/2022 10:35:48 AM
Post# of 27086

$RLMD News Article - Relmada Therapeutics Announces Top-Line Results of Study Evaluating REL-1017 vs Ketamine for Abuse Potential https://marketwirenews.com/news-releases/relm...14551.html


My Twitter: WhyteStocks